Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial

@inproceedings{Kolias2018DexamethasoneFA,
  title={Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial},
  author={Angelos G Kolias and Ellie Edlmann and Eric Peter Thelin and Diederik Bulters and Patrick Holton and Nigel Suttner and Kevin Owusu-Agyemang and Yahia Zaki Al-Tamimi and Daniel L Gatt and Simon Thomson and Ian A. Anderson and O X Durand Richards and Peter Cyril Whitfield and Monica Gherle and Karen E. Caldwell and Carol Davis-Wilkie and Silvia Tarantino and Garry Barton and Harold G. Marcus and Aswin Chari and Paul M Brennan and Alberto Belli and Simon Bond and Carole L. Turner and Lynne Whitehead and Ian Wilkinson and Peter Ja Hutchinson},
  booktitle={Trials},
  year={2018}
}
BACKGROUND Chronic subdural haematoma (CSDH) is a common neurosurgical condition, typically treated with surgical drainage of the haematoma. However, surgery is associated with mortality and morbidity, including up to 20% recurrence of the CSDH. Steroids, such as dexamethasone, have been identified as a potential therapy for reducing recurrence risk in surgically treated CSDHs. They have also been used as a conservative treatment option, thereby avoiding surgery altogether. The hypothesis of… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 2 times. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

to the methods of technology appraisal 2013

  • NICE. Guid
  • London: National Institute of Health and Clinical…
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…